Systemic activation of 15-lipoxygenase in heart, lung, and vascular tissues by hypercholesterolemia: relationship to lipoprotein oxidation and atherogenesis

Atherosclerosis - Tập 113 - Trang 247-258 - 1995
J.Martyn Bailey1, A.N. Makheja1, Richard Lee1, T.H. Simon1
1Department of Biochemistry and Molecular Biology, The George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA

Tài liệu tham khảo

Kannel, 1979, Cholesterol in the prediction of atherosclerotic disease: new perspectives in the Framingham study, Ann. Intern. Med., 90, 85, 10.7326/0003-4819-90-1-85 1970, 41, 1 Kannel, 1984, Latest perspective on cigarette smoking and cardiovascular disease: the Framingham study, J. Cardiac Rehabil., 4, 267 Bailey, 1973, Regulation of cellular cholesterol content, 63 Steinberg, 1989, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med., 320, 915 Sparrow, 1989, A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein, J. Biol. Chem., 264, 2599, 10.1016/S0021-9258(19)81655-1 Fogelman, 1980, Malondialdehyde alteration of low density lipoprotein leads to cholesterol ester accumulation in human monocyte-macrophages, 77, 2214 Parthasarathy, 1986, Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor, Arteriosclerosis, 6, 505, 10.1161/01.ATV.6.5.505 Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, 83, 3883 Steinbrecher, 1987, Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL: correlation with changes in receptor-mediated catabolism, Arteriosclerosis, 1, 135, 10.1161/01.ATV.7.2.135 Grundy, 1993, Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease, Clin. Cardiol., 16, 13, 10.1002/clc.4960161303 Quinn, 1987, Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis, 84, 2995 Goldstein, 1979, A binding site on macrophages that mediates the uptake and degradation of acetylated low density lipoprotein, 76, 333 Khoo, 1988, Enhanced macrophage uptake of low density lipoprotein after self-aggregation, Arteriosclerosis, 8, 348, 10.1161/01.ATV.8.4.348 Agel, 1984, Monocytic origin of foam cells in human artheroclerotic plaques, Atherosclerosis, 53, 265, 10.1016/0021-9150(84)90127-8 Brown, 1983, Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis, Annu. Rev. Biochem., 52, 223, 10.1146/annurev.bi.52.070183.001255 Brown, 1977, The low density lipoprotein pathway and its relation to atherosclerosis, Ann. Rev. Biochem., 46, 897, 10.1146/annurev.bi.46.070177.004341 Goldstein, 1979, A binding site on macrophages that mediates the uptake and degradation of acetylated low density lipoprotein, 76, 333 Berliner, 1990, Minimally modified LDL stimulates monocyte endothelial interaction, J. Clin. Invest., 85, 1260, 10.1172/JCI114562 Goldstein, 1979, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition, 76, 333 Henriksen, 1981, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptor for acetylated low density lipoproteins, 78, 6499 Parthasarathy, 1987, Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor, Biochem. Biophys. Acta, 917, 337, 10.1016/0005-2760(87)90139-1 Heinecke, 1984, Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture, J. Clin. Invest., 74, 1980, 10.1172/JCI111609 Palinski, 1989, Low density lipoprotein undergoes oxidative modification in vivo, 86, 1372 Herttuala, 1990, Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized LDL in macrophage-rich areas of atherosclerotic lesions, 87, 6954 Sparrow, 1988, Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification, J. Lipid Res., 29, 745, 10.1016/S0022-2275(20)38493-5 Parthasarathy, 1989, A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein, 86, 1046 Jialal, 1991, Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification, J. Clin. Invest., 87, 597, 10.1172/JCI115035 Jialal, 1990, Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein, Atherosclerosis, 82, 185, 10.1016/0021-9150(90)90039-L Sparrow, 1992, Cellular oxidative modification of LDL does not require lipoxygenases, 89, 128 Henriksson, 1985, Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall, Biochem. Biophys. Acta, 834, 272, 10.1016/0005-2760(85)90166-3 Simon, 1989, Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe heritable hyperlipidemic and cholesterol-fed rabbits, Atherosclerosis, 75, 31, 10.1016/0021-9150(89)90204-9 Simon, 1989, The induced lipoxygenase in atherosclerotic aorta converts linoleic acid to the platelet chemorepellant factor 13-HODE, Thromb. Res., 55, 171, 10.1016/0049-3848(89)90433-7 Simon, 1990, Relationship of vascular 15-lipoxygenase induction to atherosclerotic plaque formation in rabbits, Prost. Leukocytes Essent. Fatty Acids, 41, 273, 10.1016/0952-3278(90)90142-8 Schewe, 1991, Do 15-lipoxygenases have a common biological role?, Trends Biochem. Sci., 16, 369, 10.1016/0968-0004(91)90153-M Schewe, 1977, Degradation of mitochondria by cytosolic factors in reticulocytes, Acta Biol. Med. Germ., 36, 363 Schewe, 1975, A lipoxygenase in rabbit reticulocytes which attacks phospholipids and intact mitochondria, FEBS Lett., 60, 149, 10.1016/0014-5793(75)80439-X Rapoport, 1979, The lipoxygenase of reticulocytes: purification, characterization and biological dynamics of the lipoxygenase; its identity with the respiratory inhibitors of mitochondria, Eur. J. Biochem., 96, 545, 10.1111/j.1432-1033.1979.tb13068.x Bryant, 1982, Positional specificity of a reticulocyte lipoxygenase: conversion of arachidonic acid to 15S-hydroperoxyeicosatetraenoic acid (15-HETE), J. Biol. Chem., 257, 6050, 10.1016/S0021-9258(20)65103-1 Fiskum, 1985, Lipoxygenation of mitochondrial membranes by reticulocyte 15-lipoxygenase, 87 Fiskum, 1983, Influence of reticulocyte lipoxygenase and 15-HETE on mitochondrial energy coupling, 42, 2251 Cathcart, M.K., McNally, A.K. and Chisolm, G.M., Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex, J. Lipid Res., 32, 63. Vanderhoek, 1984, Activation of a 15-lipoxygenase leukotriene pathway in human PMN's by the anti-inflammatory agent ibuprofen, J. Biol. Chem., 259, 6752, 10.1016/S0021-9258(17)39792-2 McNally, 1990, Oxidation of low density lipoproteins by mammalian 15-lipoxygenase, J. Immunol., 145, 254, 10.4049/jimmunol.145.1.254 Cathcart, 1991, Production of esterified 15-HETE from intact LDL following treatment with mammalian 15-lipoxygenase, J. Lipid Res., 32, 63, 10.1016/S0022-2275(20)42244-8 Retsky, 1993, Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification, J. Biol. Chem., 268, 1304, 10.1016/S0021-9258(18)54075-8 McGuire, 1985, Cell damage unmasks 15-lipoxygenase activity in human neutrophils, J. Biol. Chem., 260, 8316, 10.1016/S0021-9258(17)39473-5 Westerman, 1970, Anemia and hypercholesterolemia in cholesterol-fed rabbits, J. Lab. Clin. Med., 75, 893 Porter, 1977, Preparation and purification of arachidonic acid hydroperoxides of biological importance, J. Org. Chem., 44, 3177, 10.1021/jo01332a017